Radiotherapy & Oncology
Volume 89, Issue 2 , Pages 156-163 , November 2008

Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer

  • Kari Tanderup

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Denmark
  • ,
  • Taran Paulsen Hellebust

      Affiliations

    • Department of Medical Physics, Rikshospital-Radiumhopital Health Trust, Oslo, Norway
  • ,
  • Stefan Lang

      Affiliations

    • Department of Radiotherapy, Medical University of Vienna, Austria
  • ,
  • Jørgen Granfeldt

      Affiliations

    • Department of Mathematical Sciences, Aarhus University, Denmark
  • ,
  • Richard Pötter

      Affiliations

    • Department of Radiotherapy, Medical University of Vienna, Austria
  • ,
  • Jacob Christian Lindegaard

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Denmark
  • ,
  • Christian Kirisits

      Affiliations

    • Department of Radiotherapy, Medical University of Vienna, Austria
    • Corresponding Author InformationCorresponding author. Christian Kirisits, Department of Radiotherapy, Medical University of Vienna, Währinger Gürtel 18-20, A – 1090 Vienna, Austria.

Received 25 October 2007 ,Revised 16 June 2008 ,Accepted 19 June 2008.

References 

  1. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:901–911
  2. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:756–764
  3. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol. 2007;
  4. Pötter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007;83:148–155
  5. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–245
  6. Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77
  7. Dimopoulos JC, Schard G, Berger D, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys. 2006;64:1380–1388
  8. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491–498
  9. Haack S, Lindegaard JC, Nielsen SK, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Brachytherapy. 2008;7:167
  10. Wachowicz K, Thomas SD, Fallone BG. Characterization of the susceptibility artifact around a prostate brachytherapy seed in MRI. Med Phys. 2006;33:4459–4467
  11. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121–1135
  12. Hellebust TP, Tanderup K, Bergstrand ES, Knutsen BH, Røislien J, Olsen DR. Reconstruction of a ring applicator using CT imaging: impact of reconstruction method and applicator orientation. Phys Med Biol. 2007;52:4893–4904
  13. Venselaar J, Pérez-Calatayud J. A practical guide to quality control of brachytherapy equipment, ESTRO, Brussels: 2004.
  14. de Crevoisier R, Tucker SL, Dong L, et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:965–973
  15. McKenzie A, van Herk M, Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol. 2002;62:299–307
  16. Stroom JC, Heijmen BJ. Limitations of the planning organ at risk volume (PRV) concept. Int J Radiat Oncol Biol Phys. 2006;66:279–286

PII: S0167-8140(08)00330-7

doi: 10.1016/j.radonc.2008.06.010

Radiotherapy & Oncology
Volume 89, Issue 2 , Pages 156-163 , November 2008